Track Jiangsu Hengrui Pharmaceuticals Co.,Ltd — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Jiangsu Hengrui Pharmaceuticals Co.,Ltd 1276.HK · Stock Open Jiangsu Hengrui Pharmaceuticals Co.,Ltd in new tab

45.08 HKD
Add to portfolio
P/E
32.24
EPS
1.35
Yield
0.47%
Safety Score
92
P/B
3.97
ROE
14.54
Beta
0.04
Target Price
78.99 HKD
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateOct. 23, 2026
P/E32.24
EPS1.35
Book Value10.95
Price to Book3.97
Debt/Equity0.11
Growth
Revenue Growth0.13%
Earnings Growth0.13%
Estimates
Forward P/E26.29
Forward EPS1.66
Target Mean Price78.99
Dividend
Dividend Yield0.47%
Annual dividends0.20 HKD
Ex-Div. DateApril 29, 2026
Payout17.16%

DCF Valuation

Tweak assumptions to recompute fair value for Jiangsu Hengrui Pharmaceuticals Co.,Ltd (1276.HK)
Currency: HKD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Jiangsu Hengrui Pharmaceuticals Co.,Ltd Logo Jiangsu Hengrui Pharmaceuticals Co.,Ltd Analysis (1276.HK)

China Healthcare Official Website Stock

Is Jiangsu Hengrui Pharmaceuticals Co.,Ltd a good investment? Jiangsu Hengrui Pharmaceuticals Co.,Ltd (1276.HK) is currently trading at 45.08 HKD. Market analysts have a consensus price target of 78.99 HKD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 32.24. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Jiangsu Hengrui Pharmaceuticals Co.,Ltd is expected to release its next earnings report on Oct. 23, 2026. The market consensus estimate for Forward EPS is 1.66.

For income investors, Jiangsu Hengrui Pharmaceuticals Co.,Ltd pays a dividend yield of 0.47%. With a payout ratio of 17%, the dividend appears sustainable.

Investor FAQ

Does Jiangsu Hengrui Pharmaceuticals Co.,Ltd pay a dividend?

Yes, it pays an annual dividend of 0.20 HKD (0.47% yield).

What asset class is Jiangsu Hengrui Pharmaceuticals Co.,Ltd?

Jiangsu Hengrui Pharmaceuticals Co.,Ltd is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Oct. 23, 2026. The company currently has a trailing EPS of 1.35.

Company Profile

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.

Exchange Ticker
HKSE 1276.HK
Trades
Dividend Yield
0.47%
Annual Dividends
0.20HKD
Next Ex. Div Date
April 29, 2026
Payout Ratio
17.16%
Dividend History paid per year (HKD)
Historical Dividends
Year Total Dividends
▸2027
0.23 HKD
May 27, 2027 (estimated) 0.2283
▸2026
0.23 HKD
May 27, 2026 0.2283
Upcoming Dividends
Name Payment Date Status Amount
Jiangsu Hengrui Pharmaceuticals Co.,Ltd May 27, 2026 0.22828 HKD
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion